Response by Butt et al to letter regarding article, “Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial”

Butt, J. H., Solomon, S. D. and McMurray, J. J.V. (2023) Response by Butt et al to letter regarding article, “Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial”. Circulation, 147(14), pp. 1119-1120. (doi: 10.1161/CIRCULATIONAHA.123.064052) (PMID:37011075)

[img] Text
296308.pdf - Accepted Version

231kB

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Butt, Mr Jawad and McMurray, Professor John
Authors: Butt, J. H., Solomon, S. D., and McMurray, J. J.V.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Circulation
Publisher:American Heart Association
ISSN:0009-7322
ISSN (Online):1524-4539
Published Online:03 April 2023
Copyright Holders:Copyright © 2023 American Heart Association, Inc.
First Published:First published in Circulation 147(14): 1119-1120
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record